301207 華蘭疫苗
按盤價 
15.130 -2.420 (-13.789%)
15.130 -2.420 (-13.789%) | 2026/09 - 九個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.082 | 3.122 | 3.348 | 14.626 | 12.514 |
| 總資產報酬率 ROA (%) | -0.068 | 2.546 | 2.649 | 11.412 | 8.960 |
| 投入資產回報率 ROIC (%) | -0.082 | 3.034 | 3.181 | 13.868 | 11.346 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.653 | 77.801 | 81.153 | 88.089 | 88.089 |
| 營業利潤率 (%) | -6.028 | 15.782 | 19.051 | 41.904 | 32.462 |
| 息稅前利潤/營業總收入 (%) | -6.583 | 15.469 | 18.397 | 41.564 | 31.989 |
| 淨利潤/營業總收入 (%) | -1.479 | 15.212 | 18.222 | 35.677 | 28.463 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 599.331 | 96.382 | 77.619 | 99.640 | 117.066 |
| 價值變動淨收益/利潤總額(%) | -307.777 | 47.678 | 46.784 | 10.942 | 12.290 |
| 營業外收支淨額/利潤總額(%) | 1.052 | -1.060 | -0.145 | -0.315 | -0.535 | 償債能力分析 |
| 流動比率 (X) | 4.635 | 3.924 | 3.399 | 3.101 | 2.728 |
| 速動比率 (X) | 4.292 | 3.764 | 3.256 | 2.998 | 2.619 |
| 資產負債率 (%) | 17.638 | 16.656 | 20.073 | 21.666 | 22.316 |
| 帶息債務/全部投入資本 (%) | 0.341 | -0.190 | 4.443 | 4.124 | 4.853 |
| 股東權益/帶息債務 (%) | 29,074.344 | -52,467.220 | 2,134.345 | 2,307.421 | 1,945.534 |
| 股東權益/負債合計 (%) | 466.963 | 500.388 | 398.192 | 361.563 | 348.118 |
| 利息保障倍數 (X) | 13.407 | -105.200 | -29.372 | -199.512 | -106.640 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 1,013.777 | 416.940 | 547.106 | 282.792 | 318.997 |
| 存貨周轉天數 (天) | 662.464 | 261.658 | 323.749 | 213.562 | 227.277 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/10/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
